Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06SFA
|
|||
| Former ID |
DNC013399
|
|||
| Drug Name |
3-(3,4-dimethylphenyl)-1,5-naphthyridine
|
|||
| Synonyms |
CHEMBL236264; 3-(3,4-dimethylphenyl)-1,5-naphthyridine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H14N2
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)C2=CC3=C(C=CC=N3)N=C2)C
|
|||
| InChI |
1S/C16H14N2/c1-11-5-6-13(8-12(11)2)14-9-16-15(18-10-14)4-3-7-17-16/h3-10H,1-2H3
|
|||
| InChIKey |
MGYKFCHFCGICOX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6525-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.